Revvity RVTY
NYSE RVTY
$129.72 +3.37 (+2.67%)
As of: Aug 27, 2026 · 3:59 PM EDT

Revvity (RVTY) Other Accumulated Expenses (2014 - 2016)

Revvity's (RVTY) quarterly Other Accumulated Expenses came in at $126.1 million in Q1 2016, up 2.59% YoY from $123.0 million in Q1 2015, and up 2.59% on a QoQ basis from $123.0 million in Q4 2014.

Revvity (RVTY) Other Accumulated Expenses (2014 - 2016) Analysis & Trends

Revvity (RVTY) has 2 years of Other Accumulated Expenses data on file, last reported at $126.1 million in Q1 2016.

  • Quarterly Other Accumulated Expenses rose 2.59% year-over-year to $126.1 million in Q1 2016, while the trailing twelve-month figure through Jan 2016 was $126.1 million (up 2.59% YoY) and the FY2016 annual result came in at $126.1 million, up 2.59% from the prior year.
  • Other Accumulated Expenses rose to $126.1 million in Q1 2016, from $123.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $126.1 million in Q1 2016 to a low of $123.0 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Revvity 14.41 Bn 13.39 Bn 416.87 Mn

Historic Data

Download Data
DateValue
Jan 3, 2016 126.14 Mn
Dec 28, 2014 122.96 Mn